This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schröder-van der Elst, J. P. Articles by Morreale de Escobar, G. Search for Related Content PubMed PubMed Citation Articles by Schröder-van der Elst, J. P. Articles by Morreale de Escobar, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LEVOTHYROXINE

Different Tissue Distribution, Elimination, and Kinetics of Thyroxine and Its Conformational Analog, the Synthetic Flavonoid EMD 49209 in the Rat¹

Human and Animal Physiology, Agricultural University, Wageningen, The Netherlands; Henning Berlin (H.R.), Berlin; and Klinische Forschergruppe, Medizinische Poliklinik, Universität Würzburg (J.K.), Wurzburg, Germany; and Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas (G.M.d.E.), Madrid, Spain

Address all correspondence and requests for reprints to: Dr. Ir. J. P. Schröder-van der Elst, Department of Human and Animal Physiology, Agricultural University, Haarweg 10, 6709 PJ Wageningen, The Netherlands. E-mail: Janny.vanderElst{at}ALG.FMD.WAU.NL

The synthetic flavonoids EMD 23188 and EMD 49209, developed as T₄ analogs, displace T₄ from transthyretin, and in vitro they inhibit 5'-deiodinase activity. In vivo EMD 21388 causes tissue-specific changes in thyroid hormone metabolism. In tissues that are dependent on T₃ locally produced from T₄, total T₃ was diminished. It was not known whether it was the presence of EMD interfering with 5'-deiodinase type II in tissues or the decreased T₄ (substrate) availability that caused the lowered T₃. To study whether the flavonoids enter tissues and, if this were the case, whether they enter tissues similarly, [¹²⁵I]EMD 49209 together with [¹³¹I]T₄ were injected into female rats and rats pretreated with EMD 21388. Tissues were extracted and submitted to HPLC. [¹²⁵I]EMD 49209 disappeared quickly from plasma and enters peripheral tissues; peak values were reached after 0.25–0.5 h. Then [¹²⁵I]EMD 49209 appeared in the intestines (after 6 h 40% of the dose). Tissue uptake of [¹³¹I]T₄ was very rapid. EMD 21388 pretreatment caused an increase in the excretion of [¹²⁵I]EMD 49209 into the intestines (40% after 0.25 h). The uptake of [¹³¹I]T₄ increased, but not high enough to ensure normal tissue T₄ concentrations. In the 5'-deiodinase type II-expressing tissues, no [¹²⁵I]EMD 49209 could be detected. We conclude that the decrease in T₃ locally produced from T₄ is caused by the shortage of T₄ as substrate and not to a direct effect of EMD on the activity of 5'-deiodinases I and II.

This article has been cited by other articles:

				C. Giuliani, Y. Noguchi, N. Harii, G. Napolitano, D. Tatone, I. Bucci, M. Piantelli, F. Monaco, and L. D. Kohn The Flavonoid Quercetin Regulates Growth and Gene Expression in Rat FRTL-5 Thyroid Cells Endocrinology, January 1, 2008; 149(1): 84 - 92. [Abstract] [Full Text] [PDF]

				J. P. S.-V. D. Elst, D. Van Der Heide, H. Rokos, G. M. De Escobar, and J. Kohrle Synthetic flavonoids cross the placenta in the rat and are found in fetal brain Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E253 - E256. [Abstract] [Full Text] [PDF]